Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a research study evaluating an investigational medication.
Uncontrolled COPD Study
Age Range:
40 to 80
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
This research study is evaluating lunsekimig, an investigational medication administered by subcutaneous injection, designed to target inflammatory pathways involved in COPD exacerbations and airway inflammation.
Qualifications
You May Be Eligible If:
- Are 40 to 80 years of age
- Have been diagnosed with COPD
- Continue to experience symptoms or COPD flare-ups despite treatment
- Have a history of moderate or severe COPD exacerbations within the past year
- Are currently using COPD controller medications as prescribed
Additional qualifications may apply during eligibility process.
FEATURED STUDIES
Heart Disease & Inflammation Study
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase
Heart Failure Prevention Study
Researchers are evaluating an investigational treatment for adults who have type 2 diabetes and cardiovascular disease and may be at
Weight & Wellness Research Study Interest
Researchers are evaluating an investigational oral treatment for adults who are overweight and may be at risk of developing certain
Flu Prevention Study Interest List
Researchers are evaluating an investigational medication that may help prevent the flu in people who are at higher risk of
General Anxiety Disorder Study
Individuals with generalized anxiety disorder (GAD) who experience ongoing worry, stress, or difficulty managing anxiety symptoms may qualify for a
Uncontrolled COPD Study
Individuals with chronic obstructive pulmonary disease (COPD) who continue to experience symptoms or flare-ups despite treatment may qualify for a